WELL Health Technologies Corp.
WELL.TO
TSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.26% | 2.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.26% | 2.69% | |||
| Cost of Revenue | 3.31% | 0.91% | |||
| Gross Profit | 5.41% | 4.90% | |||
| SG&A Expenses | 26.15% | -3.15% | |||
| Depreciation & Amortization | -16.92% | 4.90% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.90% | -0.11% | |||
| Operating Income | -39.26% | 39.24% | |||
| Income Before Tax | 165.87% | -69.72% | |||
| Income Tax Expenses | -238.55% | 62.17% | |||
| Earnings from Continuing Operations | 1,291.77% | -115.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -231.90% | 241.45% | |||
| Net Income | 442.07% | -65.51% | |||
| EBIT | -39.26% | 39.24% | |||
| EBITDA | -62.78% | 22.05% | |||
| EPS Basic | 439.50% | -65.71% | |||
| Normalized Basic EPS | -132.81% | 439.76% | |||
| EPS Diluted | 433.61% | -65.71% | |||
| Normalized Diluted EPS | -133.26% | 439.02% | |||
| Average Basic Shares Outstanding | 0.85% | 0.23% | |||
| Average Diluted Shares Outstanding | -0.55% | -0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||